Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B

First Fc Fusion therapy approved for haemophilia B in the EU to provide extended protection against bleeds STOCKHOLM--(Healthcare Sales & Marketing Network)--Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) (SOBI.ST) and Biogen (http://... Biopharmaceuticals, RegulatorySwedish Orphan Biovitrum, Sobi, Biogen, Alprolix, haemophilia B, hemophilia B
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news